<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Trusted Pharmacy Blog</title>
	<atom:link href="http://www.1trustedpharmacy.com/blog/feed" rel="self" type="application/rss+xml" />
	<link>http://www.1trustedpharmacy.com/blog</link>
	<description>New Drugs, Drug News, Health, Medications, Diseases</description>
	<lastBuildDate>Thu, 18 Mar 2010 19:30:25 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.6</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Fentanyl Buccal Tablets (Fentora)</title>
		<link>http://www.1trustedpharmacy.com/blog/fentanyl-buccal-tablets-fentora.html</link>
		<comments>http://www.1trustedpharmacy.com/blog/fentanyl-buccal-tablets-fentora.html#comments</comments>
		<pubDate>Thu, 18 Mar 2010 19:30:25 +0000</pubDate>
		<dc:creator>David</dc:creator>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[fentanyl]]></category>
		<category><![CDATA[Fentora]]></category>

		<guid isPermaLink="false">http://www.1trustedpharmacy.com/blog/?p=688</guid>
		<description><![CDATA[Cephalon has issued two &#8220;Dear Health Care Professional&#8221; letters to inform prescribers and other health care providers of important safety information regarding fentanyl buccal tablets (Fentora). Fentanyl buccal tablets are indicated only for breakthrough pain in patients with cancer who are already receiving and who are tolerant to opioid therapy for underlying persistent cancer pain.
Serious [...]]]></description>
		<wfw:commentRss>http://www.1trustedpharmacy.com/blog/fentanyl-buccal-tablets-fentora.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>IV Haloperidol (Haldol)</title>
		<link>http://www.1trustedpharmacy.com/blog/iv-haloperidol-haldol.html</link>
		<comments>http://www.1trustedpharmacy.com/blog/iv-haloperidol-haldol.html#comments</comments>
		<pubDate>Wed, 17 Mar 2010 22:22:36 +0000</pubDate>
		<dc:creator>David</dc:creator>
				<category><![CDATA[Cardiovascular]]></category>
		<category><![CDATA[Haldol]]></category>
		<category><![CDATA[Haloperidol]]></category>

		<guid isPermaLink="false">http://www.1trustedpharmacy.com/blog/?p=685</guid>
		<description><![CDATA[The FDA has announced that the prescribing information for haloperidol (Haldol, generic versions) has been revised to include a new cardiovascular subsection in the Warnings section.
Life-threatening arrhythmias (e.g., sudden death, QT prolongation, torsades de pointes) have been reported in patients treated with haloperidol, especially when the drug is administered intravenously or at doses higher than [...]]]></description>
		<wfw:commentRss>http://www.1trustedpharmacy.com/blog/iv-haloperidol-haldol.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FDA Alerts  Ceftriaxone (Rocephin)</title>
		<link>http://www.1trustedpharmacy.com/blog/fda-alerts-ceftriaxone-rocephin.html</link>
		<comments>http://www.1trustedpharmacy.com/blog/fda-alerts-ceftriaxone-rocephin.html#comments</comments>
		<pubDate>Tue, 16 Mar 2010 21:57:44 +0000</pubDate>
		<dc:creator>David</dc:creator>
				<category><![CDATA[Drug News]]></category>
		<category><![CDATA[Ceftriaxone]]></category>
		<category><![CDATA[Rocephin]]></category>

		<guid isPermaLink="false">http://www.1trustedpharmacy.com/blog/?p=682</guid>
		<description><![CDATA[Important revisions have been made to the Contraindications, Warnings, and Dosage and Administration sections of the full prescribing information for ceftriaxone (Rocephin, Roche).
This new information addresses the interaction of ceftriaxone with calcium-containing products based on reports of fatal cases in neonates. Although no cases of ceftriaxone-calcium precipitates in patients other than neonates have been reported, [...]]]></description>
		<wfw:commentRss>http://www.1trustedpharmacy.com/blog/fda-alerts-ceftriaxone-rocephin.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Asthma Guidelines Updated</title>
		<link>http://www.1trustedpharmacy.com/blog/asthma-guidelines-updated.html</link>
		<comments>http://www.1trustedpharmacy.com/blog/asthma-guidelines-updated.html#comments</comments>
		<pubDate>Mon, 15 Mar 2010 20:55:27 +0000</pubDate>
		<dc:creator>David</dc:creator>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Asthma]]></category>

		<guid isPermaLink="false">http://www.1trustedpharmacy.com/blog/?p=679</guid>
		<description><![CDATA[For the first time in a decade, the National Asthma Education and Prevention Program has updated clinical guide lines for the diagnosis and management of asthma. New features include:
•	an expanded section on asthma for children 5 to 11 years of age.
•	information on medications.
•	recommendations for patient education other than in a physician&#8217;s office.
•	advice for controlling environmental [...]]]></description>
		<wfw:commentRss>http://www.1trustedpharmacy.com/blog/asthma-guidelines-updated.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Nasal Influenza Vaccine (FluMist) Approved For Younger Children</title>
		<link>http://www.1trustedpharmacy.com/blog/nasal-influenza-vaccine-flumist-approved-for-younger-children.html</link>
		<comments>http://www.1trustedpharmacy.com/blog/nasal-influenza-vaccine-flumist-approved-for-younger-children.html#comments</comments>
		<pubDate>Sun, 14 Mar 2010 20:11:50 +0000</pubDate>
		<dc:creator>David</dc:creator>
				<category><![CDATA[Anti Viral]]></category>
		<category><![CDATA[FluMist]]></category>
		<category><![CDATA[Fluvirin]]></category>
		<category><![CDATA[influenza]]></category>

		<guid isPermaLink="false">http://www.1trustedpharmacy.com/blog/?p=676</guid>
		<description><![CDATA[The nasal influenza vaccine FluMist (MedImmune) is now approved to in clude children between two and five years of age. Approval had previously been limited to healthy children five years of age and olderand to adults up to age 49. The vaccine contains a weakened form of the live virus and is sprayed into the [...]]]></description>
		<wfw:commentRss>http://www.1trustedpharmacy.com/blog/nasal-influenza-vaccine-flumist-approved-for-younger-children.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Raloxifene (Evista): Reducing  Breast Cancer Risk In Postmenopausal Women</title>
		<link>http://www.1trustedpharmacy.com/blog/raloxifene-evista-reducing-breast-cancer-risk-in-postmenopausal-women-2.html</link>
		<comments>http://www.1trustedpharmacy.com/blog/raloxifene-evista-reducing-breast-cancer-risk-in-postmenopausal-women-2.html#comments</comments>
		<pubDate>Sat, 13 Mar 2010 21:37:43 +0000</pubDate>
		<dc:creator>David</dc:creator>
				<category><![CDATA[Women's Health]]></category>
		<category><![CDATA[Breast Cancer]]></category>
		<category><![CDATA[Evista]]></category>
		<category><![CDATA[Osteoporosis]]></category>
		<category><![CDATA[raloxifene]]></category>

		<guid isPermaLink="false">http://www.1trustedpharmacy.com/blog/?p=670</guid>
		<description><![CDATA[The FDA has approved raloxifene drags HCl (Evista, Eli Lilly) for reducing the risk of invasive breast cancer in postmenopausal women with osteoporosis and in postmenopausal women at high risk for invasive breast cancer.
As a selective estrogen receptor modulator (SERM), raloxifene may act by blocking estrogen receptors in the breast.
In 1997, the FDA approved generic [...]]]></description>
		<wfw:commentRss>http://www.1trustedpharmacy.com/blog/raloxifene-evista-reducing-breast-cancer-risk-in-postmenopausal-women-2.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Topical Human Thrombin  (Evithrom)</title>
		<link>http://www.1trustedpharmacy.com/blog/topical-human-thrombin-evithrom-2.html</link>
		<comments>http://www.1trustedpharmacy.com/blog/topical-human-thrombin-evithrom-2.html#comments</comments>
		<pubDate>Fri, 12 Mar 2010 20:16:15 +0000</pubDate>
		<dc:creator>David</dc:creator>
				<category><![CDATA[Drug News]]></category>
		<category><![CDATA[Evithrom]]></category>
		<category><![CDATA[Omrix]]></category>

		<guid isPermaLink="false">http://www.1trustedpharmacy.com/blog/?p=667</guid>
		<description><![CDATA[Evithrom (Omrix), a blood-clotting protein used to help control bleeding during surgery, is the first human thrombin approved since 1954.
Evithrom is indicated when control of bleeding by standard surgical techniques is ineffective or impractical. The productis applied to the surface of bleeding tissue. It may also be used in conjunction with an absorbable gelatin sponge. [...]]]></description>
		<wfw:commentRss>http://www.1trustedpharmacy.com/blog/topical-human-thrombin-evithrom-2.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
